165 results on '"Shastry M"'
Search Results
2. Automatic Labeling of Glycolytic Volumes In PET Using Deep Texture Analysis
3. Fintech Chatbot Using Natural Language
4. Fintech Chatbot Using Natural Language
5. 204TiP A phase II study of HER3-DXD in patients (pts) with metastatic breast cancer (MBC)
6. Evaluation of the Clinical Impact of PSMA PET-CT Imaging in the Post-radical Treatment Setting in Clinical Practice at Royal Surrey County Hospital
7. Increasing average period lengths by switching of robust chaos maps in finite precision
8. The discovery of moriniafungin, a novel sordarin derivative produced by Morinia pestalozzioides
9. Physico chemical investigation of fast ion conducting AgI−Ag2SeO4 glasses
10. Initial hydrophobic collapse in the folding of barstar
11. Abstract P1-01-16: Circulating tumor cells (CTCs) biomarker evaluation from patients with metastatic breast cancer (MBC) utilizing the TargetSelectorTM platform
12. Abstract P4-22-09: A phase 2 open label study of everolimus in combination with endocrine therapy in resistant hormone receptor-positive HER2-negative advanced breast cancer
13. Abstract P5-14-04: A phase 2 study evaluating orteronel, an inhibitor of androgen biosynthesis, in patients with androgen receptor (AR)-expressing metastatic breast cancer: Interim analysis
14. Abstract P1-12-04: A phase 2 study of eribulin in breast cancer not achieving a pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC)
15. Abstract P1-14-06: A phase II randomized study with eribulin/cyclophosphamide (ErC) and docetaxel/cyclophosphamide (TC) as neoadjuvant therapy in HER2-negative breast cancer- Final analysis of primary endpoint and correlative analysis results
16. High resolution magic angle spinning NMR studies of31P and11B in fast ion conducting AgI-Ag2O-P2O5 and AgI-Ag2O-B2O3 glasses
17. Early Events in Protein Folding Explored by Rapid Mixing Methods
18. Abstract PD4-3: Use of community-based next-generation sequencing (NGS) in advanced breast cancer: Identification of actionable targets to guide clinical trial selection
19. Abstract OT1-1-13: A phase II study with lead-in safety cohort of cabazitaxel plus lapatinib as therapy for patients with HER2-positive metastatic breast cancer (MBC) and intracranial metastases
20. Abstract P4-16-04: Amrubicin as second- or third-line treatment for patients with HER2-negative metastatic breast cancer (MBC): Final results from a phase II trial of the Sarah Cannon Research Institute (SCRI)
21. Becoming More Productive
22. Abstract P1-14-14: Neoadjuvant Sunitinib (S) Administered with Weekly Paclitaxel (P)/Carboplatin(C) in Patients (Pts) with Locally Advanced Triple-Negative Breast Cancer (TNBC): Preliminary Results from a Phase I/II Trial of the Sarah Cannon Research Institute.
23. Abstract P5-20-10: Panitumumab, Gemcitabine and Carboplatin in Triple-Negative Metastatic Breast Cancer: Preliminary Results of a Phase II Trial of the Sarah Cannon Research Institute
24. Abstract P5-17-05: Sorafenib plus Ixabepilone as First-Line Treatment for Patients with HER2-Negative Metastatic Breast Cancer: Preliminary Results of the Phase II Trial of the Sarah Cannon Research Institute
25. Abstract OT3-3-08: Eribulin/Cyclophosphamide versus Docetaxel/Cyclophosphamide as Neoadjuvant Therapy in Locally Advanced HER2-Negative Breast Cancer: A Randomized Phase II Trial of the Sarah Cannon Research Institute
26. 18F-Fludeoxyglucose PET/CT in the evaluation of large-vessel vasculitis: diagnostic performance and correlation with clinical and laboratory parameters
27. Ixabepilone and cyclophosphamide as neoadjuvant therapy in HER2-negative breast cancer with exploratory Oncotype DX assessments: A Sarah Cannon Research Institute phase II trial.
28. Neoadjuvant ixabepilone/carboplatin/trastuzumab in HER2-positive locally advanced breast cancer: A Sarah Cannon Research Institute phase II trial.
29. P222 A retrospective study of disease recurrence post thoracotomy for non-small cell lung cancer
30. A retrospective study of disease recurrence post thoracotomy for non-small cell lung cancer
31. 2107 Imaging assessment of the in vivo metabolic-vascular relationship of primary colorectal cancer by integrated 18-FDG PET/Perfusion CT – feasibility and validation with immunohistochemical markers of angiogenesis and hypoxia
32. Results of a multicenter pilot study of weekly nab-paclitaxel, carboplatin with bevacizumab, and trastuzumab as neoadjuvant therapy in HER2+ locally advanced breast cancer with SPARC correlatives
33. Preliminary safety results from a multicenter phase II trial of nanoparticle albumin-bound paclitaxel/cyclophosphamide in early stage breast cancer plus trastuzumab in HER-2+ patients (pts)
34. 38 82Rb cardiac PET/CT perfusion: initial European experience
35. 57 Value of 18F-FDG PET/CT in imaging for recurrent medullary thyroid carcinoma
36. 15 18F-FDG PET/CT response adapted treatment in childhood Hodgkin??s lymphoma
37. Sleep apnoea in end-stage renal disease: a short review of mechanisms and potential benefit from its treatment
38. Ultrarapid mixing experiments shed new light on the characteristics of the initial conformational ensemble during the folding of ribonuclease A
39. ChemInform Abstract: Kinetic and Structural Analysis of Submillisecond Folding Events in Cytochrome c
40. Kinetic and Structural Analysis of Submillisecond Folding Events in Cytochromec
41. Reversible Thermal Unfolding of Ribonuclease T1 in Reverse Micelles
42. A New Method for the Preparation of Fine-Grained SnO2and WO3Powders: Influence of the Crystallite Size on the Electrochemical Insertion of Li+in SnO2and WO3Electrodes
43. Quantitative analysis of the kinetics of denaturation and renaturation of barstar in the folding transition zone
44. Raman spectroscopic studies of As2S3 and Li2S–As2S3 glasses
45. Structural unpinning number, basicity and reciprocal electronegativity; their equivalence as ionic conductivity determinants
46. Activation barriers for d.c. conductivity in ionic glasses: Classical calculations using the small-cluster approximation
47. Near-equivalence of the role of structural unpinning number, basicity and reciprocal average electronegativity in determining the conductivity of glasses
48. Thermal and electrical properties of AgI-based composites☆
49. 18F-Fludeoxyglucose PET/CT in the evaluation of large-vessel vasculitis: diagnostic performance and correlation with clinical and laboratory parameters.
50. Phase II Study of Neoadjuvant Weekly nab-Paclitaxel and Carboplatin, With Bevacizumab and Trastuzumab, As Treatment For Women With Locally Advanced HER2(+) Breast Cancer.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.